Information
-
Trademark
-
79183455
-
Serial Number
79183455
-
Registration Number
5215665
-
International Classifications
-
Filing Date
September 17, 2015
9 years ago
-
Registration Date
June 06, 2017
7 years ago
-
Transaction Date
September 21, 2024
2 months ago
-
Status Date
December 22, 2023
12 months ago
-
Published for Opposition Date
March 21, 2017
7 years ago
-
Location Date
June 06, 2017
7 years ago
-
Status Code
709
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
MURRAY, TY
-
Attorney Name
David Perry
Law Office Assigned Location Code
M40
-
Owners
Mark Drawing Code
5
Mark Identification
PLEXPRIMER
Case File Statements
- GS0051: Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
- CC0000: Color is not claimed as a feature of the mark.
- GS0011: Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring
- GS0101: Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy
Case File Event Statements
-
2/25/2016 - 8 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
2/29/2016 - 8 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
2/29/2016 - 8 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/1/2016 - 8 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/2/2016 - 8 years ago
5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
3/2/2016 - 8 years ago
6 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
3/2/2016 - 8 years ago
7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
3/4/2016 - 8 years ago
8 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
3/19/2016 - 8 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
10/1/2016 - 8 years ago
10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
10/3/2016 - 8 years ago
11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Type: MAB2
-
11/28/2016 - 8 years ago
12 - TEAS PETITION TO REVIVE RECEIVED
Type: PROA
-
11/28/2016 - 8 years ago
13 - PETITION TO REVIVE-GRANTED
Type: PETG
-
11/28/2016 - 8 years ago
14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
11/29/2016 - 8 years ago
15 - NOTICE OF REVIVAL - MAILED
Type: NREV
-
12/9/2016 - 8 years ago
16 - ASSIGNED TO LIE
Type: ALIE
-
12/14/2016 - 8 years ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
12/14/2016 - 8 years ago
18 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
12/16/2016 - 8 years ago
19 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
12/19/2016 - 8 years ago
20 - FINAL REFUSAL WRITTEN
Type: CNFR
-
12/19/2016 - 8 years ago
21 - FINAL REFUSAL E-MAILED
Type: GNFR
-
12/19/2016 - 8 years ago
22 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
2/1/2017 - 7 years ago
23 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
2/1/2017 - 7 years ago
24 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
2/1/2017 - 7 years ago
25 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
2/1/2017 - 7 years ago
26 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
2/1/2017 - 7 years ago
27 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
2/10/2017 - 7 years ago
28 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
2/13/2017 - 7 years ago
29 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
3/1/2017 - 7 years ago
30 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
3/1/2017 - 7 years ago
31 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
3/1/2017 - 7 years ago
32 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
3/10/2017 - 7 years ago
33 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
3/17/2017 - 7 years ago
34 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
3/21/2017 - 7 years ago
35 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
3/21/2017 - 7 years ago
36 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/6/2017 - 7 years ago
37 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
9/6/2017 - 7 years ago
38 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
9/14/2017 - 7 years ago
39 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
9/14/2017 - 7 years ago
40 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
10/28/2017 - 7 years ago
41 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
6/6/2022 - 2 years ago
42 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Type: REM3
-
12/22/2023 - 12 months ago
43 - CANCELLED SECTION 71
Type: C71T
-
8/23/2024 - 3 months ago
44 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Type: INTR
-
8/31/2024 - 3 months ago
45 - INVALIDATION PROCESSED
Type: INPC
-
8/31/2024 - 3 months ago
46 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Type: INTS
-
9/20/2024 - 2 months ago
47 - TOTAL INVALIDATION PROCESSED BY THE IB
Type: INNT